Latest News

Toward a Cancer-Free World, Research and Education, Patient Stories

Cancer Patient Offers Hope and Inspiration to Others

Trial turned into triumph for Rhonda Ball, who beat cancer for a third time after enrolling in a clinical trial at The James.

Read More

Trial turned into triumph for Rhonda Ball, who beat cancer for a third time after enrolling in a clinical trial at The James.

Read More
Research and Education, Preventing Cancer

BRCA Mutation Leads to Action, Advocacy for Genetic Testing

First came surprise; then came action. A James patient took a proactive approach to breast cancer prevention after discovering the presence of a BRCA mutation.

Read More

First came surprise; then came action. A James patient took a proactive approach to breast cancer prevention after discovering the presence of a BRCA mutation.

Read More

Targeted Oral Therapy Combo Safe, Effective for Both Never-Treated and Relapsed Chronic Lymphocytic Leukemia

Acalabrutinib is a second-generation Bruton's tyrosine kinase (BTK) inhibitor, a newer class of drugs shown to improve the survival of patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).

Read More

Acalabrutinib is a second-generation Bruton's tyrosine kinase (BTK) inhibitor, a newer class of drugs shown to improve the survival of patients with chronic lymphocytic leukemia (CLL) and mantle cell...

Read More

Make an Appointment

800-293-5066

Find a Location

Search by Building Name, Doctor Name, or ZIP code

The James Cancer Hospital and Solove Research Institute

460 West 10th Avenue

Columbus, Ohio 43210

800-293-5066